StockData
ELI LILLY & Co logo

ELI LILLY & Co (LLY) operating KPIs

LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3026% above fair value
$1417.54+43.84 (+3.19%)

Close on Oct 30, 2026Market cap $1.33TP/E 46.0Yield 0.44%

Eli Lilly finished goods inventory ($M) ($M)

Form 10-Q / 10-K Inventories Note

Latest, Q2 2026
2,630
Period ended Jun 30, 2026
Change on a year earlier
+94.1%
1,355 in Q2 2025
History
18 quarters
Since Q4 2016
Sources
17
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedFinished goods inventory ($M) ($M)Year on yearSource
Q2 2026Jun 30, 20262,630+94.1%Form 10-Q (filed 2026-08-05) ↗
Q1 2026Mar 31, 20262,273+75.1%Form 10-Q (filed 2026-04-30) ↗
Q4 2025Dec 31, 20251,931+58.1%Form 10-Q (filed 2026-08-05) ↗
Q3 2025Sep 30, 20251,547+38.9%Form 10-Q (filed 2025-10-30) ↗
Q2 2025Jun 30, 20251,355+67.0%Form 10-Q (filed 2025-08-07) ↗
Q1 2025Mar 31, 20251,298+85.6%Form 10-Q (filed 2025-05-01) ↗
Q4 2024Dec 31, 20241,221+54.2%Form 10-K (filed 2026-02-12) ↗
Q3 2024Sep 30, 20241,114–Form 10-Q (filed 2024-10-30) ↗
Q2 2024Jun 30, 2024811–Form 10-Q (filed 2024-08-08) ↗
Q1 2024Mar 31, 2024700–Form 10-Q (filed 2024-04-30) ↗
Q4 2023Dec 31, 2023792-12.2%Form 10-K (filed 2025-02-19) ↗
Q4 2022Dec 31, 2022901+18.3%Form 10-K (filed 2024-02-21) ↗
Q4 2021Dec 31, 2021762+0.4%Form 10-K (filed 2023-02-22) ↗
Q4 2020Dec 31, 2020759+17.2%Form 10-K (filed 2022-02-23) ↗
Q4 2019Dec 31, 2019647+12.0%Form 10-K (filed 2021-02-17) ↗
Q4 2018Dec 31, 2018578-52.3%Form 10-K (filed 2020-02-19) ↗

Cite this data

StockData. (2026). Eli Lilly Finished goods inventory ($M) ($M), quarterly Q4 2016–Q2 2026 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/inv_fg

See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.